Trimethylamine hydrochloride
| Common Name: |
Trimethylamine hydrochloride |
| IUPAC Name: |
N,N-dimethylmethanamine;hydrochloride |
| Molecular Formula: |
C3H10ClN |
| SMILES: |
CN(C)C.Cl |
| Inchi: |
1S/C3H9N.ClH/c1-4(2)3;/h1-3H3;1H |
| Inchi Key: |
SZYJELPVAFJOGJ-UHFFFAOYSA-N |
| Cas No: |
593-81-7 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
3 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
3 |
| Name |
Value |
| Molecular Weight (g/mol) |
95.57 |
| Mass (g/mol) |
95.05 |
| Molar Refractivity |
26.40 |
| Net Charge |
|
| HBD |
|
| HBA |
1 |
| Rt Bonds |
0 |
| Rings |
|
| TPSA |
3.24 |
| Hetero Atoms |
|
| Heavy Atoms |
5 |
| Aromatic Heavy Atoms |
0 |
| Melting Point (°C) |
277.5 |
| Boiling Point (°C@760.00mm Hg) |
|
| Vapor Pressure (mmHg@25.00 °C) |
0.000016 |
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
1.00 |
| LogP |
|
| iLOGP |
0.00 |
| XLOGP3 |
1.07 |
| WLOGP |
0.98 |
| MLOGP |
0.75 |
| ESOL Log S |
-1.11 |
| ESOL Solubility (mg/ml) |
7.48 |
| ESOL Solubility (mol/l) |
0.078 |
| ESOL Class: esol_class |
Very soluble |
| Ali Log S |
-0.73 |
| Ali Solubility (mg/ml) |
17.8 |
| Ali Solubility (mol/l) |
0.19 |
| Ali Class |
Very soluble |
| Silicos-IT LogSw |
-0.20 |
| Silicos-IT Solubility (mg/ml) |
60.3 |
| Silicos-IT Solubility (mol/l) |
0.63 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
Low |
| BBB Permeable |
0 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-6.12 |
| Bioavailability Score |
0.55 |
| Caco2 |
0 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.178 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
3.101 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
